​ On the morning of April 23, 2026 (U.S. time), the Annual Meeting of the American Surgical Association (ASA) took place in Washington, D.C. Professor Zheng Minhua, from the Department of Surgery at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, was elected as an Honorary Fellow of the American Surgical Association in recognition of his outstanding contribut...

  Shanghai Jiao Tong University School of Medicine (SJTUSM) has actively aligned its efforts with national strategic needs, adhering to the national strategic priorities(known as the “Four Orientations”)and maintaining a problem-driven, mission-orientedresearch approach. The school has systematically advanced mission-oriented scientific research by pooling its resources to conduct original, ...

On March 18, the “IntMedEdu” international medical education program, hosted by the Hainan International Medical Center ofShanghai Jiao Tong University School of Medicine (SJTUSM), was officially launched with the support of the Boao Lecheng International Medical Tourism Pilot Zone. A total of 62 outstanding medical students from 13 countries worldwide will commence a two-week advanced medica...

A research team led by Professor Zhao Qiang from the Department of Cardiovascular Surgery at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, has published a landmark study in The Lancet, one of the world’s most prestigious medical journals. The study demonstrates that a quantitative flow ratio (QFR)-guided functional strategy, compared with conventional angiography-guided de...

Recently, a landmark study led by Academician Xia Qiang, President of Renji Hospital affiliated withShanghai Jiao Tong University School of Medicine (SJTUSM), was published in the top-tier international journalNature Medicine. This study represents the world’s first Phase I clinical trial using liver-targeted in vivo base editing to treat heterozygous familial hypercholesterolemia (HeFH). ...

On February 19, 2026 (Beijing Time), two landmark studies from Xinhua Hospital and Songjiang Research Institute in collaboration with other partners, were simultaneously published in Nature. The two studies achieved global breakthroughs in AI-powered diagnosis of rare diseases and gene therapy for neurodevelopmental disorders.Professor Sun Kun’s Team Unveils DeepRare: A Globally First Traceabl...